Abstract
To study the role of the BH3 domain in mediating pro-apoptotic and anti-apoptotic activities of Bcl-2 family members, we identified a series of novel small molecules (BH3Is) that inhibit the binding of the Bak BH3 peptide to Bcl-xL. NMR analyses revealed that BH3Is target the BH3-binding pocket of Bcl-xL. Inhibitors specifically block the BH3-domain-mediated heterodimerization between Bcl-2 family members in vitro and in vivo and induce apoptosis. Our results indicate that BH3-dependent heterodimerization is the key function of anti-apoptotic Bcl-2 family members and is required for the maintenance of cellular homeostasis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gross, A., McDonnell, J. M. & Korsmeyer, S. J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899–1911 (1999).
Vander Heiden, M. G. & Thompson, C. B. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nature Cell Biol. 1, E209–E216 (1999).
Tsujimoto, Y. & Shimizu, S. Bcl-2 family: life-or-death switch. FEBS Lett. 466, 6–10 (2000).
Zha, J. et al. BH3 domain of BAD is required for heterodimerization with Bcl-xL and pro-apoptotic activity. J. Biol. Chem. 272, 24101–24104 (1997).
Diaz, J. L. et al. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members. J. Biol. Chem. 272, 11350–11355 (1997).
Sattler, M. et al. Structure of Bcl-xL–Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983–986 (1997).
Chang, B. S. et al. The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L). Mol. Cell. Biol. 19, 6673–6681 (1999).
Holinger, E. P., Chittenden, T. & Lutz, R. J. Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases. J. Biol. Chem. 274, 13298–13304 (1999).
Cosulich, S. C., Worrall, V., Hedge, P. J., Green, S. & Clarke, P. R. Regulation of apoptosis by BH3 domains in a cell-free system. Curr. Biol. 7, 913–920 (1997).
Minn, A. J. et al. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature 385, 353–357 (1997).
Schendel, S. L. et al. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl Acad. Sci. USA 94, 5113–5118 (1997).
Antonsson, B. et al. Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370–372 (1997).
Minn, A. J. et al. Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J. 18, 632–643 (1999).
Conus, S. et al. Bcl-2 is a monomeric protein: prevention of homodimerization by structural constraints. EMBO J. 19, 1534–1544 (2000).
Schreiber, S. L. Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg. Med. Chem. 6, 1127–1152 (1998).
Thompson, L. A. & Ellman, J. A. Synthesis and applications of small molecule libraries. Chem. Rev. 96, 555–600 (1996).
McMillan, K. et al. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc. Natl Acad. Sci. USA 97, 1506–1511 (2000).
Young, K. et al. Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. Nature Biotechnol. 16, 946–950 (1998). (erratum, Nature Biotechnol. 16, 1074 (1998)).
Dandliker, W. B., Hsu, M. L., Levin, J. & Rao, B. R. Equilibrium and kinetic inhibition assays based upon fluorescence polarization. Methods Enzymol. 74, 3–28 (1981).
Li, H., Zhu, H., Xu, C. J. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491–501 (1998).
Zhang, M., Zamore, P. D., Carmo-Fonseca, M., Lamond, A. I. & Green, M. R. Cloning and intracellular localization of the U2 small nuclear ribonucleoprotein auxiliary factor small subunit. Proc. Natl Acad. Sci. USA 89, 8769–8773 (1992).
Lugovskoy, A. A. et al. Solution structure of the CIDE-N domain of CIDE-B and a model for CIDE-N/CIDE-N interactions in the DNA fragmentation pathway of apoptosis. Cell 99, 747–755 (1999).
Chou, J. J., Li, H., Salvesen, G. S., Yuan, J. & Wagner, G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96, 615–624 (1999).
McDonnell, J. M., Fushman, D., Milliman, C. L., Korsmeyer, S. J. & Cowburn, D. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96, 625–634 (1999).
Cryns, V. & Yuan, J. Proteases to die for. Genes Dev. 12, 1551–1570 (1998). (erratum, Genes Dev. 13, 371 (1999)).
Hsu, Y. T. & Youle, R. J. Nonionic detergents induce dimerization among members of the Bcl-2 family. J. Biol. Chem. 272, 13829–13834 (1997).
Mahajan, N. P. et al. Bcl-2 and Bax interactions in mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer. Nature Biotechnol. 16, 547–552 (1998).
Zha, J., Harada, H., Yang, E., Jockel, J. & Korsmeyer, S. J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87, 619–628 (1996).
Vander Heiden, M. G., Chandel, N. S., Schumacker, P. T. & Thompson, C. B. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol. Cell 3, 159–167 (1999).
Xiang, J., Chao, D. T. & Korsmeyer, S. J. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl Acad. Sci. USA 93, 14559–14563 (1996).
Gross, A., Jockel, J., Wei, M. C. & Korsmeyer, S. J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 3878–3885 (1998).
Matsuyama, S., Schendel, S. L., Xie, Z. & Reed, J. C. Cytoprotection by Bcl-2 requires the pore-forming α5 and α6 helices. J. Biol. Chem. 273, 30995–31001 (1998).
Hajduk, P. J., Meadows, R. P. & Fesik, S. W. Discovering high-affinity ligands for proteins. Science 278, 497–499 (1997).
Hajduk, P. J. et al. High-throughput nuclear magnetic resonance-based screening. J. Med. Chem. 42, 2315–2317 (1999).
Muchmore, S. W. et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335–341 (1996).
Shimizu, S. & Tsujimoto, Y. Proapoptotic BH3-only bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. Proc. Natl Acad. Sci. USA 97, 577–582 (2000).
Finucane, D. M., Bossy-Wetzel, E., Waterhouse, N. J., Cotter, T. G. & Green, D. R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL . J. Biol. Chem. 274, 2225–2233 (1999).
Eskes, R., Desagher, S., Antonsson, B. & Martinou, J. C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20, 929–935 (2000).
Kudla, G. et al. The destabilization of lipid membranes induced by the C-terminal fragment of caspase 8-cleaved Bid is inhibited by the N-terminal fragment. J. Biol. Chem. 275, 22713–22718 (2000).
Decaudin, D., Marzo, I., Brenner, C. & Kroemer, G. Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy. Int. J. Oncol. 12, 141–152 (1998).
Reed, J. C. Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematol. Oncol. Clin. North Am. 9, 451–473 (1995).
Miayake, H., Tolcher, A. & Gleave, M. E. Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides. J. Natl Cancer Inst. 92, 34–41 (2000).
Jansen, B. et al. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nature Med. 4, 232–234 (1998).
Baba, M., Iishi, H. & Tatsuta, M. In vivo electroporetic transfer of bcl-2 antisense oligonucleotide inhibits the development of hepatocellular carcinoma in rats. Int. J. Cancer 85, 260–266 (2000).
Kluck, R. M., Bossy-Wetzel, E., Green, D. R. & Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132–1136 (1997).
Johnson, P. E., Tomme, P., Joshi, M. D. & McIntosh, L. P. Interaction of soluble cellooligosaccharides with the N-terminal cellulose-binding domain of Cellulomonas fimi CenC 2. NMR and ultraviolet absorption spectroscopy. Biochemistry 35, 13895–13906 (1996).
Talluri, S. & Wagner, G. An optimized 3D NOESY-HSQC. J. Magn. Reson. B 112, 200–205 (1996).
Grzesiek, S. & Bax, A. Amino acid type determination in the sequential assignment procedure of uniformly 13C/15N-enriched proteins. J. Biomol. NMR 3, 185–204 (1993).
Acknowledgements
We thank C. Thompson, S. Korsmeyer, R. Reed and L. Bergeron for their gifts of the cells and expression vectors; R. Fathi, J. D. Gross, J. Tuttle, A. Fahmy and G. Heffron for experimental assistance; and R. King, B. Antonsson, A. Sinskey, P. Sorger, R. Ward, O. Gozani and N. Moerke for helpful discussions. A.D. is a recipient of a postdoctoral fellowship from the American Cancer Society. This work was supported in part by the American Heart Association Established Investigatorship and NIH grants to J.Y., by an NIH grant to G.W. and by a research grant from Biomeasure to M.C. The Institute of Chemistry and Cell Biology is supported by NIH, Merck & Co. Inc. and Merck KGaA, Darmstadt, Germany. Acquisition and maintenance of the spectrometers and computers are supported by the Giovanni Armenise-Harvard Foundation for Advanced Scientific Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Degterev, A., Lugovskoy, A., Cardone, M. et al. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat Cell Biol 3, 173–182 (2001). https://doi.org/10.1038/35055085
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/35055085
This article is cited by
-
BH3-mimetics: recent developments in cancer therapy
Journal of Experimental & Clinical Cancer Research (2021)
-
HClO4-catalyzed Diastereoselective synthesis of 2-(4-oxo-4,5-dihydrothiazol-2-yl)-2-(2-oxoindolin-3-ylidene) acetonitrile from oxindole and 4-oxo-4,5-dihydrothiazol-2-yl acetonitrile
Journal of Chemical Sciences (2021)
-
Environmentally Benign Synthesis of 4-Thiazolidinone Derivatives Using a Co/Al Hydrotalcite as Heterogeneous Catalyst
Catalysis Letters (2021)
-
2-(2-Methoxyphenyl)-3-((Piperidin-1-yl)ethyl)thiazolidin-4-One-Loaded Polymeric Nanocapsules: In Vitro Antiglioma Activity and In Vivo Toxicity Evaluation
Cellular and Molecular Neurobiology (2019)
-
Synthesis and anticancer activity of novel quinazolinone-based rhodanines
Chemistry Central Journal (2017)